These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 20833872)

  • 1. Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation.
    Chen P; Véricel E; Lagarde M; Guichardant M
    FASEB J; 2011 Jan; 25(1):382-8. PubMed ID: 20833872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation.
    Chen P; Fenet B; Michaud S; Tomczyk N; Véricel E; Lagarde M; Guichardant M
    FEBS Lett; 2009 Nov; 583(21):3478-84. PubMed ID: 19818771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes.
    Serhan CN; Gotlinger K; Hong S; Lu Y; Siegelman J; Baer T; Yang R; Colgan SP; Petasis NA
    J Immunol; 2006 Feb; 176(3):1848-59. PubMed ID: 16424216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function relationships of non-cyclic dioxygenase products from polyunsaturated fatty acids: poxytrins as a class of bioactive derivatives.
    Lagarde M; Véricel E; Liu M; Chen P; Guichardant M
    Biochimie; 2014 Dec; 107 Pt A():91-4. PubMed ID: 25223888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and anti-virus potential of poxytrins, especially protectin DX.
    Lagarde M; Guichardant M; Bernoud-Hubac N
    Biochimie; 2020 Dec; 179():281-284. PubMed ID: 32956736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Tsai WC; Kalyanaraman C; Yamaguchi A; Holinstat M; Jacobson MP; Holman TR
    Biochemistry; 2021 Jun; 60(22):1741-1754. PubMed ID: 34029049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibition.
    Pace-Asciak CR; Reynaud D; Demin P; Aslam R; Sun A
    J Pharmacol Exp Ther; 2002 May; 301(2):618-24. PubMed ID: 11961065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of oxidation products of arachidonic acid and n3 fatty acids on vascular and platelet function.
    Barden A; Mas E; Henry P; Durand T; Galano JM; Roberts LJ; Croft KD; Mori TA
    Free Radic Res; 2011 Apr; 45(4):469-76. PubMed ID: 21235285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid-derived lipid mediators and blood platelet aggregation.
    Lagarde M; Chen P; Véricel E; Guichardant M
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):227-30. PubMed ID: 20207119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets.
    Swann PG; Venton DL; Le Breton GC
    FEBS Lett; 1989 Jan; 243(2):244-6. PubMed ID: 2537230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of lipoxygenase pathway in docosapentaenoic acid-induced inhibition of platelet aggregation.
    Akiba S; Murata T; Kitatani K; Sato T
    Biol Pharm Bull; 2000 Nov; 23(11):1293-7. PubMed ID: 11085354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation.
    Kuriyama S; Kashiwagi H; Yuhki K; Kojima F; Yamada T; Fujino T; Hara A; Takayama K; Maruyama T; Yoshida A; Narumiya S; Ushikubi F
    Thromb Haemost; 2010 Oct; 104(4):796-803. PubMed ID: 20664890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHA metabolism: targeting the brain and lipoxygenation.
    Picq M; Chen P; Perez M; Michaud M; Véricel E; Guichardant M; Lagarde M
    Mol Neurobiol; 2010 Aug; 42(1):48-51. PubMed ID: 20422316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro.
    Polavarapu S; Mani AM; Gundala NK; Hari AD; Bathina S; Das UN
    PLoS One; 2014; 9(12):e114766. PubMed ID: 25536345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9 alpha-homo-9,11-epoxy-5,13-prostadienoic acid analogues: specific stable agonist (SQ 26, 538) and antagonist (SQ 26, 536) of the human platelet thromboxane receptor.
    Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Heikes JE; Sprague PW; Antonaccio MJ
    Prostaglandins; 1981 Aug; 22(2):295-307. PubMed ID: 6270744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
    PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation.
    Mas E; Croft KD; Zahra P; Barden A; Mori TA
    Clin Chem; 2012 Oct; 58(10):1476-84. PubMed ID: 22912397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.